<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><atom:link href="https://news.emory.edu/tags/topic/children.s_healthcare/index.xml" rel="self" type="application/rss+xml"/><title>Children's Healthcare</title><link>https://news.emory.edu/tags/topic/children.s_healthcare/index.html</link><description>Children's Healthcare news from the Emory News Center</description><pubDate>Sun, 02 May 2021 16:57:59 -0400</pubDate><item><title>Emory Department of Pediatrics leads nation in NIH research funding</title><link>https://news.emory.edu//stories/2021/02/emory_peds_leads_in_nih_funding/index.html</link><guid>https://news.emory.edu//stories/2021/02/emory_peds_leads_in_nih_funding/index.html</guid><description>The Department of Pediatrics in Emory's School of Medicine led the nation in federal research funding from the National Institutes of Health in 2020 among pediatric departments, according to rankings from the Blue Ridge Institute for Medical Research.</description><pubDate>Thu, 11 Feb 2021 00:00:00 -0500</pubDate></item><item><title>Emory shares in $18.2 million NIH award to continue work on COVID-19 tests</title><link>https://news.emory.edu//stories/2020/10/coronavirus_choa_emory_gatech_diagnostic_tests/index.html</link><guid>https://news.emory.edu//stories/2020/10/coronavirus_choa_emory_gatech_diagnostic_tests/index.html</guid><description>Emory, Children’s Healthcare of Atlanta and Georgia Tech have joined forces to evaluate COVID-19 diagnostic tests. The federally-funded project will lead to at-home and other point-of-care COVID tests that could provide results in minutes.</description><pubDate>Mon, 05 Oct 2020 00:00:00 -0400</pubDate></item><item><title>High antiviral antibody levels may herald pediatric COVID-19 complication </title><link>https://news.emory.edu//stories/2020/09/peds_misc_antibodies/index.html</link><guid>https://news.emory.edu//stories/2020/09/peds_misc_antibodies/index.html</guid><description>Measuring antiviral antibody levels in blood may distinguish children with multisystem inflammatory syndrome (MIS-C), which appears to be a serious but rare complication of SARS-CoV-2 infection.</description><pubDate>Tue, 08 Sep 2020 00:00:00 -0400</pubDate></item></channel></rss>